10 Microbleeds Are Not a Contraindication to Thrombolysis in Acute Stroke




10 Microbleeds Are Not a Contraindication to Thrombolysis in Acute Stroke



10.1 Case Description



10.1.1 Clinical Presentation


A 68-year-old man presented with a reduced conscious state associated with focal neurology on examination. His wife reported acute onset of left facial droop and altered conscious state at home. An ambulance was called and he was intubated in the community. He arrived at the emergency department 1 hour after onset of symptoms.


The patient had a known history of chronic atrial fibrillation (AF), and was on aspirin due to nonadherence with recommended warfarin therapy. He also had a history of congestive cardiac failure, and essential hypertension. Prior to intubation, the Glasgow Coma Score (GCS) was 4; the patient had no verbal response or eye opening, and had an extensor response to pain. Examination revealed left facial droop, extensor posturing, and positive left Babinski reflex.



10.1.2 Imaging Workup and Investigations




  • Noncontrast computed tomography (NCCT) performed 2 hours after symptom onset demonstrates no acute ischemic changes (Fig. 10.1).



  • Subsequent CT angiography (CTA) demonstrated a filling defect in the tip of the basilar artery extending into the left and right P1 segments.

    Fig. 10.1 NCCT was unremarkable.


10.2 Diagnosis


Occlusive basilar artery thrombosis.



10.3 Treatment



10.3.1 Initial Management




  • Patient received intravenous thrombolysis 4.5 hours after the onset of symptoms.



10.3.2 Endovascular Management




  • Endovascular clot retrieval was conducted at 5.5 hours with Trevo device.



  • 1-cm clot was removed from basilar artery with Trevo device. Some residual clot was seen in the right superior cerebellar artery (SCA) (Fig. 10.2).

    Fig. 10.2 Basilar artery thrombosis before (left) and after (right) successful mechanical thrombectomy.


10.3.3 Outcome




  • The patient had an excellent response to therapy. He was able to follow commands after sedation was weaned on the same day.



  • He was extubated on day 2 of admission, and discharged from intensive care on day 3.



  • He was discharged from the hospital 2 weeks later; on discharge he was able to ambulate independently, with some residual deficits in dynamic balance.



  • MRI performed 3 months later showed a large infarct involving the pons, as well as multiple small cerebellar infarcts (Fig. 10.3). Multiple cerebral microbleeds (CMBs) were also identified in a lobar distribution (Fig. 10.4).

    Fig. 10.3 Red oval—MRI T2 sequence showing pontine infarcts; red arrows—small cerebellar infarct.
    Fig. 10.4 Red arrows—multiple cerebral microbleeds in a lobar distribution.


10.4 Discussion



10.4.1 Background


Thrombolysis and mechanical thrombectomy are therapies proven to improve clinical outcomes following acute ischemic stroke. 1 ,​ 2 ,​ 3 ,​ 4 ,​ 5 ,​ 6 However, tissue plasminogen activator (tPA) increases the risk of intracerebral hemorrhage (ICH). 7 The risk of ICH may also be increased in people with multiple lobar CMBs. 8 Identification of CMBs on MRI therefore invites the question, is thrombolysis indicated in patients with CMBs who present with acute ischemic stroke?


CMBs are small hypointense lesions, visible on susceptibility weight imaging and gradient echo (GRE) MRI sequences that represent hemosiderin-laden macrophage deposits in areas of angiopathy. 9 Risk of CMBs increases with age, with prevalence of CMBs reported to be around 25% in a general older population of mean age 68 years. 10 ,​ 11 They are a marker of frailty, have been shown to correlate with severity of white matter lesions (WML), and found to be an independent predictor of cognitive dysfunction. 12 ,​ 13


CMBs that occur in the lobar regions have been associated with cerebral amyloid angiopathy, carriage of the apolipoprotein e4 allele, and raised diastolic blood pressure (BP), while those that are infratentorial or deep are associated with cardiovascular risk factors such as hypertension, as well as subcortical infarcts, and WML on MRI. 11 ,​ 14 ,​ 15


In observational studies, CMBs have been associated with an increased risk of ICH, and an increased risk of hematoma expansion in patients with ICH. 8 ,​ 16 ,​ 17 ,​ 18 CMBs may also increase the risk of ICH in patients taking antiplatelet drugs. 18 ,​ 19


In a recent meta-analysis of five observational studies by Shoamanesh et al, there was a nonsignificant trend toward an increased risk of symptomatic and asymptomatic ICH after thrombolysis, in patients with CMBs compared to those without. 20 These studies were limited by small sample size and inconsistent methodology; thus, further studies are required.



10.4.2 Workup and Diagnosis



History

The patient’s history of AF, congestive cardiac failure, hypertension, and age put him at high risk for cardioembolic stroke. Risk stratification using the CHA2DS2VASc criteria gives him a score of 3, which is associated with an annual risk of AF-related thromboembolism of around 5%. 21



Examination and Investigations

On presentation, there were clear focal neurological symptoms, associated with a reduced conscious state. The patient’s thrombolysis was delayed to confirm the stroke team clinical suspicion of basilar thrombosis by obtaining CTA. Obtaining further imaging after NCCT should not delay intravenous thrombolysis where it is indicated.


MRI performed subacutely showed a large pontine infarct accounting for the patient’s altered consciousness and other symptoms, as well as multiple cerebellar infarcts that resulted in the residual deficits in dynamic balance.



10.4.3 Decision-Making Process


The decision to perform thrombolysis requires a diagnosis of ischemic stroke causing a measurable neurological deficit, with onset of symptoms no longer than 4.5 hours prior to beginning treatment in patients 18 years or older. 1 See Table 10.1 for a list of absolute and relative exclusion criteria. Endovascular clot retrieval has been shown to be superior to thrombolysis alone. 2














thrombolysis microbleeds as contraindication thrombolysis exclusion criteria, acute ischemic stroke microbleeds as thrombolysis contraindication basilar artery thrombosis microbleeds as thrombolysis contraindication Table 10.1 Exclusion criteria for thrombolysis for acute ischemic stroke 1
Absolute exclusion criteria Patient may not receive thrombolysis if any of the below criteria are met

Significant head trauma or prior stroke in previous 3
mo

Symptoms suggest subarachnoid hemorrhage

History of previous intracranial hemorrhage

Intracranial neoplasm, arteriovenous malformation

Elevated blood pressure (systolic >185 mm Hg or
diastolic >110 mm Hg)

Arterial puncture at noncompressible site in previous 7
d

CT demonstrates multilobar infarction (hypodensity >1/3
cerebral hemisphere)

Recent intracranial or intraspinal surgery

Active internal bleeding

Platelet count <100,000/mm3

Heparin received within 48 h, resulting in elevated
aPTT

Current use of anticoagulant with INR >1.7

Current use of direct thrombin inhibitors or direct factor
Xa inhibitors with elevated sensitive laboratory
tests

Blood glucose concentration <50 mg/dL (2.7
mmol/L)

Acute bleeding diathesis

Relative exclusion criteria Patient may receive thrombolysis after consideration of risk versus benefit, if one or more of the below criteria are met

Only minor or rapidly improving stroke symptoms

Pregnancy

Seizure at onset with postictal residual neurological
impairments

Acute myocardial infarction in last 3 mo

Major surgery or serious trauma within previous 14
d

Recent gastrointestinal or urinary tract hemorrhage
(within previous 21 d)

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Apr 30, 2022 | Posted by in CARDIOLOGY | Comments Off on 10 Microbleeds Are Not a Contraindication to Thrombolysis in Acute Stroke

Full access? Get Clinical Tree

Get Clinical Tree app for offline access